The rise in cardiovascular diseases globally has resulted in a higher number of interventional procedures, necessitating the use of arteriotomy closure devices. Arteriotomy closure devices are essential in managing access sites after procedures such as angiography or vascular interventions. Valued at $641 million in 2024, the arteriotomy closure devices market is projected to reach sales of $873 million by 2033, registering a compound annual growth rate (CAGR) of 2.9% during 2024-33, according to GlobalData, a leading data and analytics company.

Tina Deng, MSc, Principal Medical Devices Analyst at GlobalData, comments: “Arteriotomy closure devices are experiencing consistent growth in various markets, indicating advancements in technology that enhance their effectiveness and usability. For example, Vascade from Haemonetics has gained popularity in the market due to its user-friendly design and efficacy in achieving hemostasis.”

According to GlobalData’s SKU Premium product, the market share of the Vascade series almost doubled from 2021 to 2024 in the US. The average selling price of Vascade MVP has increased 0.8% yearly. The device minimizes trauma to the vascular site, improving patient comfort and satisfaction post-procedure.

There are two types of arteriotomy closure devices, including passive closure devices and active closure devices. The key differences between active and passive arteriotomy closure devices lie in their mechanisms of action—active devices engage in mechanical closure while passive devices facilitate natural clotting.

The decision between active and passive closure devices is influenced by procedural needs, patient-specific factors, expected healing outcomes, technical considerations, operator experience, and the characteristics of the devices themselves. The advancements in materials and design are likely contributing factors to the growth of both active and passive closure devices.

Deng concludes: “Innovations such as bio-absorbable materials, enhanced suturing techniques, and improved delivery systems are making these devices safer and more effective for patients undergoing procedures requiring vascular access.”